• / Free eNewsletters & Magazine
  • / My Account
Home>Merck obtains right to experimental Ebola vaccine

Merck obtains right to experimental Ebola vaccine

3party Content

Mon, 24 Nov 2014

By Peter Loftus Merck & Co. has obtained the rights to an experimental Ebola vaccine developed by NewLink Genetics Corp., another sign of the scramble by pharmaceutical companies and other groups to find new ways to combat the deadly viral outbreak centered in West Africa. The companies said Merck
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.